Adult: 20-25 mg/kg as a single dose or preferably in 2 or 3 divided doses at 6-8 hrs interval. Max dose 1.5 g.
Child: 20-25 mg/kg taken in 2 divided doses.
Prophylaxis of malaria
Adult: 250 mg once wkly taken 1-3 wk before exposure and continuing for 4 wk after leaving the malarious area.
Child: <45 kg: 250 mg once wkly; 30-45 kg: 187.5 mg once wkly; 20-30 kg: 125 mg once wkly; 10-20 kg: 62.5 mg once wkly; 5-10 kg: 31.25 mg once wkly. Start prophylaxis 1-3 wk before exposure and continue for 4 wk after leaving malarious area.
Treatment with quinine during the preceding 12 hr. Prophylaxis in patients with history of psychiatric illness, seizure, hepatic disorder. Co-admin with halofantrine due to increased risk of cardiac arrhythmias.
Warnings / Precautions
Epilepsy; delay admin until at least 12 hr after the last dose of quinine/quinine-related compounds (monitoring of cardiac and neurological functions is warranted). Avoid driving or operating machines during and up to 3 wk after mefloquine use. Pregnancy, lactation; cardiac conduction disturbances; children <3 mth or 5 kg.
Adverse Reactions
Nausea, vomiting, abdominal pain, diarrhoea; dysphoria, dizziness; headache; sleep disorders; vertigo; neuropsychiatric reactions; bradycardia; visual/auditory disturbances; pruritus; sialorrhea, arthralgia and fatigue; syncope; extrasystole.
Potentially Fatal: Seizures, thrombocytopenia, leucopenia, AV block, encephalopathy.
Drug Interactions
Mefloquine may compromise adequate immunization by live typhoid vaccine. Increased risk of ventricular arrhythmias with amiodarone, atomoxetine, ivrabradine, moxifloxacin, pimozide. Increased risk of cardiac toxicity and/or convulsions when used with quinidine, quinine, chloroquine and hydroxychloroquine. May antagonise anticonvulsant effects of antiepileptics. Bradycardia may occur with digoxin, calcium channel blockers and β-blockers.
Potentially Fatal: Avoid concommitant use with halofantrine as potentially fatal cardiac arrythmias may occur.
See Below for More mefloquine Drug Interactions
Mechanism of Actions
Mefloquine is a 4-methanolquinine antimalarial which acts as a blood schizontocide. It is active against most Plasmodium species and is used both as prophylaxis and treatment against malaria.
Absorption: Well absorbed from the GIT (oral).
Distribution: Widely distributed; small amount enters breast milk, crosses placenta. Protein-binding: 98%
Metabolism: Hepatic (small amounts).
Excretion: Urine (as unchanged drug and metabolites), faeces. Elimination half-life: 2-4 wk
Should be taken with food. (Best taken w/ meals & a full glass of water.)
ATC Classification
P01BC02 - mefloquine ; Belongs to the class of methanolquinoline antimalarials.
Available As
  • Mefloquine 250 mg
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Mefloquine

    Mefloquine Containing Brands

    We are Developing Our database, More results coming soon.

    Mefloquine is used in following diseases

    We are Developing Our database, More results coming soon.

    Drug - Drug Interactions of Mefloquine

    We are Developing Our database, More results coming soon.